The results showed that EZH2 significantly promoted tumor growth in vivo and the proliferation of cervical cancer cells in vitro by accelerating the cell cycle transition of cervical cancer cells from G0/G1 phase to S phase (Figure 2 and 3). Here, EZH2 is linked to cervical cancer.